Latest / The BioHub - by Avetix
JP Morgan David Happel
Our little spin off of our time at JPM!
Big announcements and exclusives! Here we have David Happel, CEO of Sagimet Biosciences
Listen to hear how they've been doing.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.